Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 When ligand becomes receptor--tolerance via B7 signaling on DCs.

× No keyword cloud information.

32 in total

Review 1. Co-stimulation blockade as a new strategy in kidney transplantation: benefits and limits.

Authors: Renaud Snanoudj; Julien Zuber; Christophe Legendre
Journal: Drugs Date: 2010-11-12 Impact factor: 9.546

2. Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation.

Authors: Ursula Hainz; Petra Obexer; Christiana Winkler; Peter Sedlmayr; Osamu Takikawa; Hildegard Greinix; Anita Lawitschka; Ulrike Pötschger; Dietmar Fuchs; Stephan Ladisch; Andreas Heitger
Journal: Blood Date: 2005-01-27 Impact factor: 22.113

3. T regulatory cell function in idiopathic minimal lesion nephrotic syndrome.

Authors: Carlos Araya; Leila Diaz; Clive Wasserfall; Mark Atkinson; Wei Mu; Richard Johnson; Eduardo Garin
Journal: Pediatr Nephrol Date: 2009-06-03 Impact factor: 3.714

Review 4. Advances in immunosuppression for renal transplantation.

Authors: Antoine Durrbach; Helene Francois; Severine Beaudreuil; Antoine Jacquet; Bernard Charpentier
Journal: Nat Rev Nephrol Date: 2010-02-02 Impact factor: 28.314

Review 5. Cancer Clonal Theory, Immune Escape, and Their Evolving Roles in Cancer Multi-Agent Therapeutics.

Authors: Jonathan L Messerschmidt; Prianka Bhattacharya; Gerald L Messerschmidt
Journal: Curr Oncol Rep Date: 2017-08-12 Impact factor: 5.075

6. No augmentation of indoleamine 2,3-dioxygenase (IDO) activity through belatacept treatment in liver transplant recipients.

Authors: S Bigenzahn; B Juergens; B Mahr; J Pratschke; A Koenigsrainer; T Becker; D Fuchs; G Brandacher; A Kainz; F Muehlbacher; T Wekerle
Journal: Clin Exp Immunol Date: 2018-02-02 Impact factor: 4.330

When ligand becomes receptor--tolerance via B7 signaling on DCs.

Review 1. Co-stimulation blockade as a new strategy in kidney transplantation: benefits and limits.

2. Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation.

3. T regulatory cell function in idiopathic minimal lesion nephrotic syndrome.

Review 4. Advances in immunosuppression for renal transplantation.

Review 5. Cancer Clonal Theory, Immune Escape, and Their Evolving Roles in Cancer Multi-Agent Therapeutics.

6. No augmentation of indoleamine 2,3-dioxygenase (IDO) activity through belatacept treatment in liver transplant recipients.

7. Phenotypic characterization of regulatory T cells in the human decidua.

Review 8. Indoleamine 2,3-dioxygenase and tumor-induced tolerance.

9. Urinary CD80 excretion increases in idiopathic minimal-change disease.

10. The blockade of T-cell co-stimulation as a therapeutic stratagem for immunosuppression: Focus on belatacept.